OBJECTIVE: The purpose of this study was to investigate the effectiveness of intratympanic dexamethasone injection as a protection agent against cisplatin-induced ototoxicity
Cisplatin (cisdiaminodichloroplatinum) (CDDP) is a chemotherapeutic agent often used in the treatmen...
Objectives: The aim of this study was to investigate the protective effects of a sustained release f...
Background: Cisplatin is a commonly used anti-cancer drug. However, its use is associated with sever...
OBJECTIVE: The purpose of this study was to investigate the effectiveness of intratympanic dexametha...
The purpose of this study was to investigate the effectiveness of intratympanic dexamethasone inject...
Introduction: Cisplatin chemotherapy causes ototoxicity manifested as sensorineural hearing loss and...
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this...
SIMSEK, GOKCE/0000-0001-5281-0986WOS: 000496697400005PubMed: 31531774Purpose The main aim of this st...
Abstract Purpose: To evaluate the ability of dexamethasone to protect against cisplatin (CDDP)-ind...
The otoprotective effects of OTO-104 were investigated following both acute and chronic administrati...
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this...
Cisplatin ototoxicity is a major dose-limiting factor in the treatment of several neoplasms. Dexamet...
The aim of this study was to investigate the potential protective effect of thymoquinone against cis...
PubMed: 31569969Ototoxicity is the general name of cochlear and vestibular organ injury resulting fr...
Aim: To compare the protective effect of dexamethasone and lactate against cisplatin-induced ototoxi...
Cisplatin (cisdiaminodichloroplatinum) (CDDP) is a chemotherapeutic agent often used in the treatmen...
Objectives: The aim of this study was to investigate the protective effects of a sustained release f...
Background: Cisplatin is a commonly used anti-cancer drug. However, its use is associated with sever...
OBJECTIVE: The purpose of this study was to investigate the effectiveness of intratympanic dexametha...
The purpose of this study was to investigate the effectiveness of intratympanic dexamethasone inject...
Introduction: Cisplatin chemotherapy causes ototoxicity manifested as sensorineural hearing loss and...
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this...
SIMSEK, GOKCE/0000-0001-5281-0986WOS: 000496697400005PubMed: 31531774Purpose The main aim of this st...
Abstract Purpose: To evaluate the ability of dexamethasone to protect against cisplatin (CDDP)-ind...
The otoprotective effects of OTO-104 were investigated following both acute and chronic administrati...
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this...
Cisplatin ototoxicity is a major dose-limiting factor in the treatment of several neoplasms. Dexamet...
The aim of this study was to investigate the potential protective effect of thymoquinone against cis...
PubMed: 31569969Ototoxicity is the general name of cochlear and vestibular organ injury resulting fr...
Aim: To compare the protective effect of dexamethasone and lactate against cisplatin-induced ototoxi...
Cisplatin (cisdiaminodichloroplatinum) (CDDP) is a chemotherapeutic agent often used in the treatmen...
Objectives: The aim of this study was to investigate the protective effects of a sustained release f...
Background: Cisplatin is a commonly used anti-cancer drug. However, its use is associated with sever...
DOI
Add to ORKG